Get the app!
Back to Companies

Bambusa Therapeutics, Inc.

BBTXNasdaqCIK: 0002044950

Recent Form 4 activity at Bambusa Therapeutics, Inc. (BBTX) spans 14 filings across 9 insiders (all of them on the buy side). Purchases total $58.6M against $0 in sales — heavily weighted toward buying, for a net purchase of $58.6M. RA CAPITAL MANAGEMENT, L.P. is the most active by dollar volume, and the single largest transaction was $46.6M by RA CAPITAL MANAGEMENT, L.P.. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.

Total Volume
$64.7M
Purchases
$58.6M
Sales
$0
Unique Insiders
9

Recent Insider Trades

14 loaded
Nov 2BBTX
Bambusa Therapeutics, Inc.
Xu ShanshanInsiderConversion$0
Nov 2BBTX
Bambusa Therapeutics, Inc.
Salvia Investment GmbHInsiderBuy$6.0M
Nov 2BBTX
Bambusa Therapeutics, Inc.
Jeggle Helmut WolfgangInsiderBuy$6.0M
Nov 3BBTX
Bambusa Therapeutics, Inc.
RA CAPITAL MANAGEMENT, L.P.InsiderBuy$46.6M
Oct 29BBTX
Bambusa Therapeutics, Inc.
Ho Minh Quoc ThangInsiderOther$0
Nov 2BBTX
Bambusa Therapeutics, Inc.
Xu ShanshanInsiderAward$6.1M
Oct 29BBTX
Bambusa Therapeutics, Inc.
RA CAPITAL MANAGEMENT, L.P.InsiderOther$0
Oct 29BBTX
Bambusa Therapeutics, Inc.
Liang HowardInsiderOther$0
Oct 29BBTX
Bambusa Therapeutics, Inc.
DiRocco DerekInsiderOther$0
Oct 29BBTX
Bambusa Therapeutics, Inc.
Salvia Investment GmbHInsiderOther$0
Oct 29BBTX
Bambusa Therapeutics, Inc.
Lieber Jonathan IInsiderOther$0
Oct 29BBTX
Bambusa Therapeutics, Inc.
Jeggle Helmut WolfgangInsiderOther$0
Oct 29BBTX
Bambusa Therapeutics, Inc.
Xu ShanshanInsiderOther$0
Oct 29BBTX
Bambusa Therapeutics, Inc.
Foerster Christian UweInsiderOther$0

14 filings